Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non Operating Income (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Other Non Operating Income data on record, last reported at $171000.0 in Q2 2025.

  • For Q2 2025, Other Non Operating Income rose 115.52% year-over-year to $171000.0; the TTM value through May 2025 reached -$3000.0, up 99.9%, while the annual FY2025 figure was -$3000.0, 99.9% up from the prior year.
  • Other Non Operating Income reached $171000.0 in Q2 2025 per LFCR's latest filing, down from $333000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $333000.0 in Q1 2025 and bottomed at -$23.4 million in Q2 2023.
  • Average Other Non Operating Income over 5 years is -$1.9 million, with a median of -$200500.0 recorded in 2022.
  • Peak YoY movement for Other Non Operating Income: crashed 875.24% in 2024, then skyrocketed 140.91% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $109000.0 in 2021, then plummeted by 317.43% to -$237000.0 in 2022, then tumbled by 308.02% to -$967000.0 in 2023, then skyrocketed by 68.56% to -$304000.0 in 2024, then soared by 156.25% to $171000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $171000.0 in Q2 2025, $333000.0 in Q1 2025, and -$304000.0 in Q4 2024.